Category: Science


Advancing Melanoma Research in Times of Uncertainty

By Cody R. Barnett, MRA Director of Communications | 9 June 2021 In Allies & Partnerships, Melanoma Stories, Policy, Prevention, Science, Treatment

Each year, the annual MRA Scientific Retreat brings hundreds of people from across the melanoma research ecosystem together to exchange ideas, report on scientific progress, celebrate achievements, and mourn the losses. In these ways, the 2021 Retreat was no different.

Read More


Separating Hope From Hype in Melanoma Research

By Cody R. Barnett, MRA Director of Communications | 4 June 2021 In Science, Treatment

In the last decade alone 13 therapeutic approaches have earned FDA approval giving patients, families, and clinicians new tools to treat melanoma. But there can be a fine line between hope and hype, especially today when news — both true and inflated — travels instantly via the internet and social media.

Read More


MRA's Acral Melanoma Cell Line Catalog: A Launching Pad for Research

By Raj Talukdar, MRA Science Intern | 25 May 2021 In Science

In a collaborative effort to facilitate research focused on acral melanoma, MRA has created and annotated a catalog of acral melanoma cell lines from various institutions worldwide. The catalog includes cell lines created by researchers at Memorial Sloan Kettering Cancer Center, Wistar Institute, Yale University, the University of Zurich, the Queensland Institute of Medical Research in Australia and more.

Read More


Firming the Foundation: Pathology, Rare Melanomas, and Moving the Field Forward

By Cody R. Barnett, MRA Director of Communications | 21 May 2021 In Science, Treatment

When Dr. Priyadharsini Nagarajan talks about her work at MD Anderson Cancer Center, her energy and excitement could light up any room. That’s because Dr. Nagarajan – a pathologist who specializes in skin (called a ‘dermatopathologist’) – sees her work as critical to creating a firm foundation for all subsequent...

Read More


Melanoma Research Alliance Announces $8.1 million in Research Awards

By Cody R. Barnett, MRA Director of Communications | 27 April 2021 In News, Prevention, Science, Treatment

The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce $8.1 million in funding for 34 new research awards. The awards, issued on the cusp of Melanoma Awareness Month, provide critical funding to address urgent unmet needs in melanoma.

Read More


A New Treatment Approach in the Arsenal: Neoadjuvent Therapy

23 April 2021 In Allies & Partnerships, News, Science, Treatment

Surgery is the backbone of melanoma treatment and is curative for the vast majority of patients with localized melanoma. However, even if surgery successfully removes all detectible traces of tumor tissue, some patients will still experience a melanoma relapse. Can neoadjuvant therapy, an experimental approach, reduce the risk of recurrence?

Read More


UV Exposure & Risk of Cutaneous Melanoma in Skin of Color

By Rachel Fischer, Ph.D., Senior Associate, Scientific Program and Grants Administration | 14 April 2021 In News, Prevention, Science

In JAMA Dermatology, a team led by Adewole S. Adamson, MD, from The University of Texas at Austin, investigates whether there is an association, specifically in People of Color, between UV exposure and melanoma. MRA breaks down what this research means and how it should impact your sun safety practices.

Read More


Dr. James Allison on the Path to More Effective Immunotherapies

24 March 2021 In Science, Treatment

When MRA co-founder and Board Chair Debra Black introduced James Allison of the University of Texas MD Anderson Cancer Center at MRA’s 2020 Scientific Retreat, she described him as the man “who changed the way cancer patients are treated forever.” This fitting introduction is due to Allison’s pioneering work to mainstream the...

Read More


Relentless in the Fight: Dr. F. Stephen Hodi

5 March 2021 In Melanoma Stories, Science

Every revolution needs trailblazers—people who restlessly and relentlessly search for paths forward. At MRA, we’re fortunate to partner with innovative trailblazers who are guiding the entire field of melanoma further, such as two time MRA-funded investigator Dr. F. Stephen Hodi.

Read More


Estimating Melanoma Risk by Examining Skin’s Mutational Burden

By Cody R. Barnett, MRA Director of Communications | 10 February 2021 In Prevention, Science

 We’ve known for decades that most melanomas – formed from the color-producing cells in our skin called melanocytes – are predominantly caused by UV-radiation-induced damage from the sun or indoor tanning devices. This damage is cumulative but is often invisible.

Read More


Login

×